- Conditions
- Colorectal Cancer (CRC), Head and Neck Squamous Cell Carcinoma (HNSCC), Metastatic Castration-resistant Prostate Cancer (mCRPC), Non Small Cell Lung Cancer Squamous (NSCLC-Sq), Pancreatic Ductal Adenocarcinoma (PDAC), Small Cell Lung Cancer (SCLC)
- Interventions
- MEDI7247
- Drug
- Lead sponsor
- MedImmune LLC
- Industry
- Eligibility
- 18 Years to 101 Years
- Enrollment
- 8 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 2
- States / cities
- Huntersville, North Carolina • Nashville, Tennessee
Source: ClinicalTrials.gov public record
Updated Dec 29, 2019 · Synced May 8, 2026, 2:53 AM EDT